Multiple fusion antigens for use in immunoassays for anti-HCV antibodies
US6797809B2 · kind B2 · utility
3Cited by
10References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 8, 2003 |
| Grant date | Sep 28, 2004 |
| Priority date | — |
| Expiry date | Aug 8, 2023 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/20
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
HCV immunoassays comprising an NS3/4a conformational epitope and a multiple epitope fusion antigen are provided, as well as immunoassay solid supports for use with the immunoassays.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.